Novo CEO: The pandemic has increased the value of collaborations and deals
For pharmaceutical company Novo Nordisk, the Covid-19 pandemic has been a good opportunity to optimize a string of processes in connection with partnerships and potential acquisitions.
BY BENJAMIN WERNER CHRISTENSEN, TRANSLATED BY DANIEL PEDERSEN
The Covid-19 pandemic has made a lot of things more difficult - but not everything.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk upgrades guidance
For subscribers
US-based obesity firm hires former Novo VP
For subscribers
